OpenAlex | Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005)

Work

Year: 2023

Type: article

Source: Vaccine

Authors Anthonet Koen, Alane Izu, Vicky L. Baillie, Gaurav Kwatra, Clare Cutland +31 more

Institutions South African Medical Research Council, University of the Witwatersrand, Christian Medical College & Hospital, Setshaba Research Centre, University of Cape Town +13 more

Cites: 20

Cited by: 4

Related to: 10

FWCI: 1.255

Citation percentile (by year/subfield): 76.25

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

Sustainable Development Goal Good health and well-being

Open Access status: bronze

Funders Bill and Melinda Gates Foundation, AstraZeneca, UK Research and Innovation, University of Oxford, South African Medical Research Council